Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
Authors
Keywords
Parkinson's disease, Neurofilament light chain, Phenotypes, Progression, Biomarkers
Journal
PARKINSONISM & RELATED DISORDERS
Volume 87, Issue -, Pages 41-47
Publisher
Elsevier BV
Online
2021-04-28
DOI
10.1016/j.parkreldis.2021.04.016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories
- (2020) Stefanie Lerche et al. MOVEMENT DISORDERS
- Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease
- (2020) Frederic Sampedro et al. PARKINSONISM & RELATED DISORDERS
- Is There a Value of Neurofilament Light as a Biomarker for Neurodegeneration in Parkinson's Disease?
- (2020) Henrik Zetterberg MOVEMENT DISORDERS
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression
- (2020) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Serum NFL discriminates Parkinson disease from atypical parkinsonisms
- (2019) Tainá M. Marques et al. NEUROLOGY
- Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies
- (2019) Andrea Pilotto et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Blood NfL
- (2019) Chin-Hsien Lin et al. NEUROLOGY
- Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease
- (2018) Andrea Pilotto et al. NEUROLOGY
- Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials
- (2017) Alberto J. Espay et al. MOVEMENT DISORDERS
- Precision medicine for disease modification in Parkinson disease
- (2017) Alberto J. Espay et al. Nature Reviews Neurology
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Vascular Risk Factors and Cognition in Parkinson’s Disease
- (2016) Andrea Pilotto et al. JOURNAL OF ALZHEIMERS DISEASE
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease
- (2015) David C. Bäckström et al. JAMA Neurology
- New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression
- (2015) Seyed-Mohammad Fereshtehnejad et al. JAMA Neurology
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now